搜尋結果
Headache; GI symptoms (including nausea, vomiting, diarrhoea &/or abdominal pain); myalgia; inj site reactions (eg, pain, redness, swelling), fatigue, chills, fever. Inj site pruritus, malaise. Click to view Shingrix detailed prescribing information. Drug Interactions.
Adult 500 mL/dose infused via peripheral vein at infusion rate of 500 mL administered over 120 min. Max dose: 2,500 mL/day. Adjust dose according to patient's condition, body wt & age. Click to view BFLUID Injection detailed prescribing information. Contraindications. Hypersensitivity.
Treatment of uncomplicated flu in patients ≥12 yr. Post-exposure prophylaxis of flu in individuals ≥12 yr. Click to view Xofluza detailed prescribing information. Dosage/Direction for Use.
Pneumonia, upper resp tract infection, bronchitis, influenza, candidiasis of mouth & throat; oropharyngeal pain, sinusitis, pharyngitis, rhinitis, cough, dysphonia; abdominal pain; arthralgia, back pain, fractures, muscle spasms; pyrexia. Click to view Relvar Ellipta detailed prescribing information. Drug Interactions.
Description. View Codaewon description for details of the chemical structure and excipients (inactive components). Action. View Codaewon mechanism of action for pharmacodynamics and pharmacokinetics details. MIMS Class. Cough & Cold Preparations.
Nervous system disorders: Dizziness, drowsiness, headache, dysarthria, grand mal seizures. General disorders and admin site conditions: Sweating. Respiratory, thoracic and mediastinal disorders: Hypersecretion in respiratory tract. Vascular disorder: Hypotension. Patient Counseling Information.
Add-on therapy for treatment of chronic spontaneous urticaria (CSU) in adults & adolescents ≥12 yr w/ inadequate response to H 1 -antihistamine treatment. Click to view Xolair detailed prescribing information. Dosage/Direction for Use.